RT Journal Article
SR Electronic
T1 No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 3
SP 20
OP 21
DO 10.1177/155989771103012
UL http://mdc.sagepub.com/content/11/3/20.abstract
AB Results from the Surgical Treatment of Ischemic Heart Failure STICH trial [NCT00023595] showed no mortality benefit from coronary artery bypass grafting in addition to intensive guideline-based medical therapy compared with medical therapy alone.